Readouts for safety and efficacy are an important research area in inherited retinal diseases research and their clinical interventions. Due to the cell-specific effects on retinal cells in inherited retinal diseases, visual functions and retinal morphology are not affected equally over the phenotypes. A careful choice of diagnostics to assess efficacy, but also safety is needed.

Fr18-01 Retinal imaging - outcome and safety measure in IRD trials and clinic

·       Philipp Herrmann (Bonn)

Fr18-02 What do we have to consider in testing rod function?

·       Krunoslav Stingl (Tübingen)

Fr18-03 Structural and functional outcome measures for Stargardt disease

·       Hendrik Scholl (Basel, Schweiz)

Fr18-04 Outcome measures for clinical trials: The patient perspective

·       Avril Daly (Dublin, Irland)

Fr18-05 What does work and what does not in gene therapy?

·       Mark Pennesi (Portland, Vereinigte Staaten)

Bitte wenden Sie sich direkt an den Organisator.

Sie sind der Organisator oder Veranstalter?
Möchten Sie die Anmeldung hier verlinken?
Wir haben passende Angebote für die Bewerbung Ihrer Veranstaltung. Nehmen Sie einfach Kontakt mit EYEFOX auf:
+49 (0) 30 403 6422-0 (Telefon) und info@eyefox.com (E-Mail)!